Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice

Nature Nanotechnology

Volumn 11, Issue 7, 2016, Pages 613-620

  Xue, Xue ^a   Yang, Jing Yu ^b   He, Yi ^c   Wang, Li Rong ^a   Liu, Ping ^b   Yu, Li Sha ^b   Bi, Guo Hua ^c   Zhu, Ming Ming ^b   Liu, Yue Yang ^b   Xiang, Rong Wu ^b   Yang, Xiao Ting ^b   Fan, Xin Yu ^b   Wang, Xiao Min ^b   Qi, Jia ^c   Zhang, Hong Jie ^d   Wei, Tuo ^a   Cui, Wei ^b   Ge, Guang Lu ^a   Xi, Zheng Xiong ^c   Wu, Chun Fu ^b   Liang, Xing Jie ^a   more..

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; AMINO ACIDS; MAMMALS; NANOTUBES; NEUROPHYSIOLOGY; YARN;

CONDITIONED PLACE PREFERENCES; ELECTROCHEMICAL ASSAYS; EXTRACELLULAR; PRE-TREATMENT; STRIATUM; SYNAPTIC PROTEINS; THERAPEUTIC EFFECTS; TYROSINE HYDROXYLASE;

SINGLE-WALLED CARBON NANOTUBES (SWCN);

AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; DOPAMINE; METHAMPHETAMINE; SINGLE WALLED NANOTUBE; SYNAPTOPHYSIN; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2; CARBON NANOTUBE; DOPAMINE TRANSPORTER; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFECT; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; ELECTROCHEMICAL ANALYSIS; MESOLIMBIC DOPAMINERGIC SYSTEM; METHAMPHETAMINE DEPENDENCE; MICROINJECTION; MOUSE; NEUROCHEMISTRY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; THERAPY EFFECT; VENTRAL STRIATUM; WITHDRAWAL SYNDROME; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; EATING; MALE; METABOLISM;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EATING; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NANOTUBES, CARBON; PROTEIN BINDING; TYROSINE 3-MONOOXYGENASE;

EID: 84961233880     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2016.23     Document Type: Article

References (32)

1. Vocci F. J, & Appel N. M. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 102, 96-106 (2007).
2. Giraldo J. P, et al. A ratiometric sensor using single chirality near-infrared fluorescent carbon nanotubes: application to in vivo monitoring. Small 11, 3973-3984 (2015).
3. Khan A. A, et al. Tunable scattering from liquid crystal devices using carbon nanotubes network electrodes. Nanoscale 7, 330-336 (2015).
4. Xue X, et al. Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer?s disease. Nano Lett. 14, 5110-5117 (2014).
5. Lee H. J, et al. Amine-modified single-walled carbon nanotubes protect neurons from injury in a rat stroke model. Nature Nanotech. 6, 121-125 (2011).
6. Ma X. W, et al. Single-walled carbon nanotubes alter cytochrome c electron transfer and modulate mitochondrial function. ACS Nano 6, 10486-10496 (2012).
7. Wang L. R, et al. Structure-dependent mitochondrial dysfunction and hypoxia induced with single-walled carbon nanotubes. Small 10, 2859-2869 (2014).
8. Figueiredo-Filho L. C, Silva T. A, Vicentini F. C, & Fatibello-Filho O. Simultaneous voltammetric determination of dopamine and epinephrine in human body fluid samples using a glassy carbon electrode modified with nickel oxide nanoparticles and carbon nanotubes within a dihexadecylphosphate film. Analyst 139, 2842-2849 (2014).
9. Tiwari J. N, Vij V, Kemp K. C, & Kim K. S. Engineered carbon-nanomaterialbased electrochemical sensors for biomolecules. ACS Nano 10, 46-80 (2016).
10. Yang C, Denno M. E, Pyakurel P, & Venton B. J. Recent trends in carbon nanomaterial-based electrochemical sensors for biomolecules: A review. Anal. Chim. Acta. 887, 17-37 (2015).
11. Wise R. A. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox. Res. 14, 169-183 (2008).
12. Chiu V. M, & Schenk J. O. Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system. Curr. Drug Abuse Rev. 5, 227-242 (2012).
13. O?Brien C. P, & Gardner E. L. Critical assessment of how to study addiction and its treatment: Human and non-human animal models. Pharmacol. Ther. 108, 18-58 (2005).
14. Pickens C. L, et al. Neurobiology of the incubation of drug craving. Trends Neurosci. 34, 411-420 (2011).
15. Keller C. M, et al. Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat. Psychopharmacology 215, 513-526 (2011).
16. Shepard J. D, Chuang D. T, Shaham Y, & Morales M. Effect of methamphetamine self-Administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology 185, 505-513 (2006).
17. Zhu J, et al. Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens. J. Neurosci. Res. 90, 895-904 (2012).
18. Robinson T. E, & Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47, 33-46 (2004).
19. Song R, et al. Increased vulnerability to cocaine in mice lacking dopamine D3 receptors. Proc. Natl Acad. Sci. USA 109, 17675-17680 (2012).
20. Xi Z. X, et al. Brain cannabinoid CB2 receptors modulate cocaine?s actions in mice. Nature Neurosci. 14, 1160-1166 (2011).
21. Arnold M. S, Green A. A, Hulvat J. F, Stupp S. I, & Hersam M. C. Sorting carbon nanotubes by electronic structure using density differentiation. Nature Nanotech. 1, 60-65 (2006).
22. Edwards S. L, Werkmeister J. A, & Ramshaw J. A. M. Carbon nanotubes in scaffolds for tissue engineering. Expert Rev. Med. Devices 6, 499-505 (2009).
23. Keefer E. W, Botterman B. R, Romero M. I, Rossi A. F, & Gross G. W. Carbon nanotube coating improves neuronal recordings. Nature Nanotech. 3, 434-439 (2008).
24. Suzuki I, Fukuda M, Shirakawa K, Jiko H, & Gotoh M. Carbon nanotube multi-electrode array chips for noninvasive real-Time measurement of dopamine, action potentials, and postsynaptic potentials. Biosens. Bioelectron. 49, 270-275 (2013).
25. Bardi G, et al. Functionalized carbon nanotubes in the brain: cellular internalization and neuroinflammatory responses. PLoS ONE 8, e80964 (2013).
26. Wang L, Zhang L, Xue X, Ge G. L, & Liang X. J. Enhanced dispersibility and cellular transmembrane capability of single-wall carbon nanotubes by polycyclic organic compounds as chaperon. Nanoscale 4, 3983-3989 (2012).
27. Qi J, et al. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. N. S. Arch. Pharmacol. 376, 441-448 (2008).
28. Qi J, et al. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 56, 856-865 (2009).
29. Han W. Y, et al. Oxytocin via its receptor affects restraint stress-induced methamphetamine CPP reinstatement in mice: involvement of the medial prefrontal cortex and dorsal hippocampus glutamatergic system. Pharmacol. Biochem. Behav. 119, 80-87 (2013).
30. Qi J, et al. A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons. Nature Commun. 5, 5390 (2014).
31. Colonnier M, & Beaulieu C. An empirical assessment of stereological formulae applied to the counting of synaptic disks in the cerebral cortex. J. Comp. Neurol. 231, 175-179 (1985).
32. DeFelipe J, Marco P, Busturia I, & Merchan-Perez A. Estimation of the number of synapses in the cerebral cortex: methodological considerations. Cereb. Cortex. 9, 722-732 (1999).